iiinova — where your digital self keeps evolving

ProfMakris @profmakris.bsky.social · 15/05/2025

Recombinant ADAMTS13 should be the standard of care for patients with congenital TTP. FFP is an inferior product both in terms of efficacy and safety. A paper in the journal Blood describes the experience from Japan in 14 patients. lnkd.in/eXg345SD

1112

ProfMakris @profmakris.bsky.social · 14/05/2025

For anybody interested in birds, this is a great book. The author tried to learn more about birds by building a shed/hide close to his home in the south of England. Very well researched and informative. I learnt a lot about the birds we encounter in the UK.

030

ProfMakris @profmakris.bsky.social · 07/05/2025

If you are interested in birds, the Greek island of Lesbos is a great place to visit this time of the year, as it coincides with the spring migration. We saw 170 species of bird in one week thanks to the skills of "Mr Lesbos Birding" Howard Vaughan, who also took the bird pictures below.

050

ProfMakris @profmakris.bsky.social · 05/05/2025

My commentary on PITT (PF4-associated immune thrombocytopenia and thrombosis) has just been published in the British Journal of Haematology. This group of disorders is more than HIT and VITT and we should be looking for it more widely. onlinelibrary.wiley.com/doi/10.1111/...

091

ProfMakris @profmakris.bsky.social · 21/04/2025

Our editorial on the Paradox of Choice in Hemophilia has just been published in the journal Research and Practice in Thrombosis and Haemostasis. Like all papers in this journal, it is freely available. tinyurl.com/4kw9hcth @rpth.bsky.social #hemophilia #haemophilia

081

ProfMakris @profmakris.bsky.social · 18/04/2025

Thank you. In addition, there were no cases of malignancy following gene therapy, but the number of patients and years of follow-up is small.

020

ProfMakris @profmakris.bsky.social · 18/04/2025

A paper in @NEJM describes 14 patients with #hemophilia B who had the Pfizer gene therapy. Their achieved FIX levels remained stable over a median of 5.5 years. Confirmation that durability following hemophilia B gene therapy is very different to that in hemophilia A. tinyurl.com/2b2zzc37

040

ProfMakris @profmakris.bsky.social · 18/04/2025

An article in the current issue of @nejm.org discusses the impact of the US foreign assistance cuts on global health. Some of the impacts are not readily obvious. The authors advocate reforming the foreign assistance program rather than dismantling it.

020

ProfMakris @profmakris.bsky.social · 18/04/2025

The BIC meeting in Italy is always a great meeting, showcasing the latest science and with plenty of time for discussion. Remember the deadline for abstract submission is the 30th April 2025. #hemophilia #VWD #TMA #TTP

010

ProfMakris @profmakris.bsky.social · 17/04/2025

Today is #WorldHemophiliaDay and this year's theme is that women and girls bleed too. Despite the development of brilliant treatments to treat severe #hemophilia primarily in men, the diagnosis and treatment of women have not received as much attention.

082

ProfMakris @profmakris.bsky.social · 11/04/2025

This is the press release about the new #hemophilia B gene therapy that has been approved in China. So there are now 3 approved gene therapies for hemophilia B, 2 in US/Europe approved by the FDA/EMA and 1 in China approved by the Chinese regulator. tinyurl.com/2jc74nb9

tinyurl.com

Belief BioMed and Takeda China jointly announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved

/PRNewswire/ -- Belief BioMed ("BBM") and Takeda China today jointly announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been...

020

ProfMakris @profmakris.bsky.social · 10/04/2025

Thank you for the copies of the paper on the UK Infected Blood Inquiry that was published in @BloodJournal. It is interesting to see the section on lessons learned. Despite the @bloodinquiry, the UK continues to use cryo and FFP without viral inactivation. #hemophilia

042

ProfMakris @profmakris.bsky.social · 10/04/2025

Article on Generative AI in medicine published today in @nejm.org. It discusses the potential uses and risks. One issue you can be sure of, is that AI will be embedded in the everyday practice of medicine in the very near future, even more than today. tinyurl.com/4sbjpjvs

000

Reposted by ProfMakris

EAHAD - European Association for Haemophilia and Allied Disorder @eahad.bsky.social · 10/04/2025

Join Cedric Hermans and @profmakris.bsky.social in this E-learning Insight session as they share practical strategies and key considerations to help you navigate the world of scientific publishing. Learn how to write with purpose and make your research stand out.📺 academy.eahad.org/eahad/2023/e...

043

ProfMakris @profmakris.bsky.social · 08/04/2025

If you are a scientist who is not using AI yet, this article from today's @nature.com journal will be of great help. Whether we like it or not, AI will be everywhere very soon, just like the internet.

020

ProfMakris @profmakris.bsky.social · 06/04/2025

Everybody has an opinion about racism, but as the author of this book explains, the plural of anecdote is not data. This is a serious book looking at the scientific evidence around racism. It will not come as a surprise to read that racism is still in everything.

020

Reposted by ProfMakris

Ken Milne MD @thesgem.bsky.social · 05/04/2025

Pseudoscience. #MedSky

1167

ProfMakris @profmakris.bsky.social · 04/04/2025

Vaccination skeptics should have a look at this figure. It shows the impact of the introduction of RSV vaccination for patients aged 75-80 on hospital admissions in the UK. tinyurl.com/5d48u7mm

0164

ProfMakris @profmakris.bsky.social · 03/04/2025

Important paper: In patients with cancer and venous thrombosis, extended anticoagulation with low dose Apixaban is as good as full dose Apixaban in preventing thrombosis recurrence and is associated with less bleeding. tinyurl.com/yyfuan35

0133

ProfMakris @profmakris.bsky.social · 03/04/2025

Professor Christine Lee reflects on some of the conclusions of the UK Infected Blood Inquiry. The manuscript has just been published by the journal Haemophilia. @haemophilia_jnl #hemophilia. The PDF of the manuscript is freely available at: tinyurl.com/mvh2mk22

030

ProfMakris @profmakris.bsky.social · 03/04/2025

Our paper on the severity of #hemophilia has just been published in the journal Hemasphere. Baseline clotting factors do not always accurately reflect the severity of the disease. tinyurl.com/3hn9hhrn

tinyurl.com

Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype

You have to enable JavaScript in your browser's settings in order to use the eReader.

010

ProfMakris @profmakris.bsky.social · 03/04/2025

Our paper on inhibitor trends is now published in the journal Haemophilia. The number of inhibitors in previously untreated patients has markedly reduced, but it is possible that this is due to delayed exposure to FVIII. tinyurl.com/2mr3t5e3

081

ProfMakris @profmakris.bsky.social · 31/03/2025

Comprehensive review of gene therapy in #hemophilia accepted for publication by Molecular Therapy. The pre-proof is on line at tinyurl.com/3sb4nuex

043

ProfMakris @profmakris.bsky.social · 31/03/2025

Paying reviewers to assess papers submitted to scientific journals results in more rapid reviews, but the quality does not change. News article in @nature.com. tinyurl.com/bdfxf9xy

tinyurl.com

Publishers trial paying peer reviewers — what did they find?

Two journals embarked on efforts to compensate reviewers, with different results.

030

ProfMakris @profmakris.bsky.social · 30/03/2025

Incredible: dropbox.com/scl/fi/qy2ja.... This podcast was produced 100% by AI. It is entirely based on the editorial by myself and Brian O'Mahony published in @rpth.bsky.social. It is 21 min and remarkably accurate. Thank you, Eugene Fan, for showing me what is possible.

050

ProfMakris @profmakris.bsky.social · 30/03/2025

This is an amazingly prophetic book written by two Harvard professors who teach political science. Although published in 2018, it clearly describes what is happening in the world and the US in particular today. "History does not repeat itself; it rhymes."

020

Reposted by ProfMakris

RPTH @rpth.bsky.social · 28/03/2025

Do you want the latest updates in #platelet research? 🔥 Check out these Illustrated Capsules from the Advanced Course in Platelet Research held in Spain in September 2024. Supported by @isth.org and the SETH www.rpthjournal.org/article/S247...

073

ProfMakris @profmakris.bsky.social · 28/03/2025

As expected the FDA has today announced that it has approved Fitusiran for individuals aged 12+ with #hemophilia A or B with or without inhibitors. Commercial name is Qfitlia - they must have tried hard to find a difficult to pronounce name. tinyurl.com/mr4xmawt

tinyurl.com

FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

Today, the FDA approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies).

051

ProfMakris @profmakris.bsky.social · 27/03/2025

Tomorrow, March 28th, is the big day for Fitusiran as the FDA is expected to give their decision. Will they approve it? Probably. Will it have a black box warning? We do not know, but since they did not use them for Marstacimab and Concizumab, they will probably not. #hemophilia

030

ProfMakris @profmakris.bsky.social · 27/03/2025

If you are still unsure whether to ask for your data to be deleted by 23andMe and any retained samples destroyed, have a read of this article in the New England Journal of Medicine @nejm.org.

011

ProfMakris @profmakris.bsky.social · 26/03/2025

Our editorial on #hemophilia treatments and the paradox of choice is now available in the journal Research and Practice in Thrombosis and Haemostasis. www.rpthjournal.org/article/S247...

030

ProfMakris @profmakris.bsky.social · 26/03/2025

Von Willebrand disease associated angiodysplasia can be challenging to manage. I suspect the best treatment will be targeting angiogenesis rather than VWD. Excellent review on the subject in Haematologica. tinyurl.com/vu7n9w5h

030

ProfMakris @profmakris.bsky.social · 24/03/2025

If you have used 23andme.com for analysis of your genome like me, you may wish to read this document from the California Attorney General about requesting deletion of your data and destruction of your sample before the company is taken over. oag.ca.gov/news/press-r...

23andme.com

DNA Genetic Testing For Health, Ancestry And More - 23andMe

23andMe offers DNA testing with the most comprehensive ancestry breakdown, personalized health insights and more.

010

ProfMakris @profmakris.bsky.social · 23/03/2025

I bought this book when META/Facebook (who claim to believe in free speech) got a Gag order to stop the author promoting the book! The author was a senior employee at Facebook, and this is her memoir. What she writes about Facebook will shock all readers because the results impact everybody.

0135

Reposted by ProfMakris

Dr Louella Vaughan @drlkvaughan.bsky.social · 17/03/2025

I am running for Clinical VP of the RCP. For those who don't know me, here is a potted bio. 🧵

12919

Reposted by ProfMakris

Geoffrey Barnes, MD, MSc @gbarnesmd.bsky.social · 14/03/2025

Access to affordable rivaroxaban 2.5mg tablets could be a game changer for patients with PAD. This drug, when combined with low-dose aspirin, prevents MI, stroke, and limb amputations!

031

ProfMakris @profmakris.bsky.social · 13/03/2025

The generic versions of the Direct Oral Anticoagulants (DOACs) are coming. First FDA approval for generic Rivaroxaban (Xarelto) 2.5mg tablets. The real need is for the 10, 15, and 20 mg tablets; let's hope the delay is not too long. Also for the other DOACs. tinyurl.com/ypmmmnmf

tinyurl.com

FDA Approves First Generics of Xarelto

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce the risk of stroke and deep vein thrombosis.

141

ProfMakris @profmakris.bsky.social · 12/03/2025

The new dosing method for Fitusiran appears to provide equal efficacy without thrombotic events. The number of patients, however, is very small. Safety will only be demonstrated with real world data on a much larger number of patients. tinyurl.com/mupbhanr

020

Reposted by ProfMakris

Otto English @ottoenglish.bsky.social · 06/03/2025

Public opinion of Putin and Trump I'm Spain, France, UK and Italy. For some peculiar reason the graphs look better on their side.

32492105

Reposted by ProfMakris

Anton Gerashchenko @antongerashchenko.bsky.social · 06/03/2025

"The defeat of #Ukraine would be the defeat of Europe. The Baltic States, Georgia and Moldova are already on the list. Putin’s goal is to return to Yalta, where half the continent was ceded to Stalin." - French Senator Claude Malhuret made an excellent speech.

521855487

Reposted by ProfMakris

Adam Schwarz @adamjschwarz.bsky.social · 05/03/2025

French Senator Claude Malhuret: "Washington has become Nero’s court, with an incendiary emperor, submissive courtiers and a jester high on ketamine... We were at war with a dictator, we are now at war with a dictator backed by a traitor."

16548126825622

ProfMakris @profmakris.bsky.social · 04/03/2025

Obituary of an Australian blood donor. Despite having only one lung, he donated 1173 times between 1954 and 2018 and contributed to every batch of anti-D made in Australia. Amazingly, in Australia, the maximum age for blood donation is 81 years. tinyurl.com/yme2hck8

tinyurl.com

James Harrison, whose blood donations saved over 2 million babies, has died

Harrison, whose plasma contained a rare antibody, rolled up his sleeve 1,173 times from 1954 to 2018. The Australian is credited with helping 2.4 million babies and advancing scientific research.

0101

ProfMakris @profmakris.bsky.social · 03/03/2025

Editorial in the @NEJM about the current assault on science in the US. "As editors, we should continue to do what we think makes a difference.

080

Reposted by ProfMakris

Omid Seidizadeh @omidseidi.bsky.social · 02/03/2025

I often use Google Scholar as a reliable alternative tool.

021

Reposted by ProfMakris

Robin Conibere @pharmrj.pharmsky.app · 02/03/2025

Have a look at www.dimensions.ai as suggested by @altmetric.com bsky.app/profile/altm...

011

Reposted by ProfMakris

Echinatum @echinatum.bsky.social · 02/03/2025

EuropePMC relies on a feed (feeds ?) from PubMed. As I understand, it can run on its own, but I do not know how it will get updated and synchronised with PubMed. Though it does collect some data separately. I hope EuropePMC had prepared as much as they could for this predictable event.

053

ProfMakris @profmakris.bsky.social · 02/03/2025

Does anybody know how independent the European site (europepmc.org) is from PubMed? Can EuropePMC go it alone without any links to PubMed? 2/2 #PubMed

europepmc.org

Europe PMCHome - Europe PMC

Europe PMC is an archive of life sciences journal literature.

421

ProfMakris @profmakris.bsky.social · 02/03/2025

With Kennedy/Trump/Musk in charge, it is possible that PubMed will be taken down permanently (unlikely), charge for use if outside the US (possible), decide what is included or excluded (probable). 1/2 #PubMed

010

ProfMakris @profmakris.bsky.social · 02/03/2025

PubMed is down. I was hoping this was temporary, but this morning it is still down. PubMed is the site I use most for medicine. I hope this is not a Kennedy/Trump action. The European site europepmc.org works and is similar, but I do not know the relationship to PubMed.

europepmc.org

Europe PMCHome - Europe PMC

Europe PMC is an archive of life sciences journal literature.

133